Trials / Conditions / Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7
4 registered clinical trials studyying Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer NCT03468218 | Emory University | Phase 2 |
| Active Not Recruiting | Testing the Addition of M6620 (VX-970, Berzosertib) to Usual Chemotherapy and Radiation for Head and Neck Canc NCT02567422 | National Cancer Institute (NCI) | Phase 1 |
| Recruiting | Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy NCT01810913 | National Cancer Institute (NCI) | Phase 2 / Phase 3 |
| Completed | Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recur NCT01064479 | M.D. Anderson Cancer Center | Phase 2 |